Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 6
1988 6
1989 15
1990 25
1991 25
1992 38
1993 41
1994 65
1995 70
1996 80
1997 73
1998 98
1999 109
2000 122
2001 145
2002 146
2003 162
2004 240
2005 324
2006 328
2007 359
2008 359
2009 455
2010 579
2011 767
2012 842
2013 1040
2014 1181
2015 1454
2016 1374
2017 1416
2018 1438
2019 800
2020 43
Text availability
Article attribute
Article type
Publication date

Search Results

12,753 results
Results by year
Filters applied: . Clear all
Page 1
Epigenetic Regulation of EMT in Non-Small Cell Lung Cancer.
O'Leary K, Shia A, Schmid P. O'Leary K, et al. Curr Cancer Drug Targets. 2018;18(1):89-96. doi: 10.2174/1568009617666170203162556. Curr Cancer Drug Targets. 2018. PMID: 28176646 Review.
Non-small cell lung cancer - mutations, targeted and combination therapy.
Kutkowska J, Porębska I, Rapak A. Kutkowska J, et al. Postepy Hig Med Dosw (Online). 2017 May 17;71(0):431-445. doi: 10.5604/01.3001.0010.3826. Postepy Hig Med Dosw (Online). 2017. PMID: 28513466 Review.
Non-Small Cell Lung Cancer, Version 6.2015.
Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Dilling TJ, Dobelbower MC, Govindan R, Grannis FW Jr, Horn L, Jahan TM, Komaki R, Krug LM, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Schild SE, Shapiro TA, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M; National comprehensive cancer network. Ettinger DS, et al. J Natl Compr Canc Netw. 2015 May;13(5):515-24. doi: 10.6004/jnccn.2015.0071. J Natl Compr Canc Netw. 2015. PMID: 25964637
Expression Analysis of OIP5-AS1 in Non-Small Cell Lung Cancer.
Esfandi F, Kholghi Oskooei V, Taheri F, Kiani A, Taheri M, Ghafouri-Fard S. Esfandi F, et al. Klin Onkol. 2018 Summer;31(4):260-263. doi: 10.14735/amko2018260. Klin Onkol. 2018. PMID: 30541307 English.
CRTC2 promotes non-small cell lung cancer A549 migration and invasion in vitro.
Shi S, Luo W, Zhang R, Wang C, Zheng Y, Song Y, Wang R, Zhang L, Zhang L, Li W, Luo Z. Shi S, et al. Thorac Cancer. 2018 Jan;9(1):136-141. doi: 10.1111/1759-7714.12550. Epub 2017 Nov 3. Thorac Cancer. 2018. PMID: 29105369 Free PMC article.
Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non-Small Cell Lung Cancer.
Gettinger SN, Wurtz A, Goldberg SB, Rimm D, Schalper K, Kaech S, Kavathas P, Chiang A, Lilenbaum R, Zelterman D, Politi K, Herbst RS. Gettinger SN, et al. J Thorac Oncol. 2018 Jun;13(6):831-839. doi: 10.1016/j.jtho.2018.03.008. Epub 2018 Mar 22. J Thorac Oncol. 2018. PMID: 29578107 Free PMC article.
12,753 results
Jump to page
Feedback